Not logged in...
About USC Norris
FAQ - Trials
Contact Us - Trials
Support USC Norris
» Contact Us
If you are a patient, please contact
Keck Medical Center of USC
A Randomized, Open-Label, Multi-Center Phase IIIB Study Comparing Two Trastuzumab Dosing Regimens, Each in Combination with Cisplatin/Capecitabine Chemotherapy, as First-Line Therapy in Patients with HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Adenocarcinoma Who Have Not Received Prior Treatment for Metastatic Disease.
Not Open (Closed)
Defintions of terms and FAQ about clinical trials.
Syma Iqbal, M.D.
Other Trial Staff:
Ramona Lujan, R.N., Taison Tran, D.M., Khatchik Karakozian, D.M., Catherine Ticong, R.N.
to see study documents.
Click here to see trial eligibility criteria and further details at ClinicalTrials.gov
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.